Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03554629 · ClinicalTrials.gov registry record · NA
A Comparison of Capnography Sampling Lines
A NA study of Capnography, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03554629 is a NA study of Capnography that has completed, run by Medtronic - MITG. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03554629, a NA study of Capnography, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the performance of eight (8) cleared capnography carbon dioxide (CO2) sampling filterlines during patient simulated scripted activities when connected to a Medtronic (MDT) dual parameter monitor.
Conditions Studied
Interventions
- DEVICE Capnography CO2 cannula sampling Flexiterline (CCSF) designs with supplemental O2
Study Locations (1)
Colorado
- Clinimark LLC - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2020-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03554629
The ClinicalTrials.gov registry entry for NCT03554629 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Capnography appearing as the primary indexed condition, and to 1 intervention - of which Capnography CO2 cannula sampling Flexiterline (CCSF) designs with supplemental O2 is the first listed.
NCT03554629 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03554629 about?
NCT03554629 is a clinical study titled "A Comparison of Capnography Sampling Lines". This study evaluates the performance of eight (8) cleared capnography carbon dioxide (CO2) sampling filterlines during patient simulated scripted activities when connected to a Medtronic (MDT) dual parameter monitor.
What is the current status of trial NCT03554629?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-05-01. Estimated completion is 2020-09-15.
What conditions does trial NCT03554629 study?
This clinical trial studies the following conditions: Capnography.
What interventions are being tested in trial NCT03554629?
The interventions under investigation include: Capnography CO2 cannula sampling Flexiterline (CCSF) designs with supplemental O2 (DEVICE).
Who is sponsoring clinical trial NCT03554629?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03554629 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.